 Connection
Lee Newman to Chronic Disease
This is a "connection" page, showing publications Lee Newman has written about Chronic Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.156 |
|
|
|
-
Jinnett K, Schwatka N, Tenney L, Brockbank CV, Newman LS. Chronic Conditions, Workplace Safety, And Job Demands Contribute To Absenteeism And Job Performance. Health Aff (Millwood). 2017 02 01; 36(2):237-244.
Score: 0.332
-
Dally M, Ogden P, Howard S, Hubbell Z, Golden A, Van Dyke M, Cragle D, Benade W, Stalker J, Newman LS. Longitudinal Surveillance for Chronic Health Conditions in Former United States Department of Energy Site Workers. J Occup Environ Med. 2025 May 01; 67(5):e328-e335.
Score: 0.145
-
Schwatka NV, Shore E, Atherly A, Weitzenkamp D, Dally MJ, Brockbank CVS, Tenney L, Goetzel RZ, Jinnett K, McMillen J, Newman LS. Reoccurring Injury, Chronic Health Conditions, and Behavioral Health: Gender Differences in the Causes of Workers' Compensation Claims. J Occup Environ Med. 2018 08; 60(8):710-716.
Score: 0.092
-
Tooker BC, Ozawa K, Newman LS. CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge. J Immunotoxicol. 2016 05; 13(3):417-27.
Score: 0.077
-
Tooker BC, Brindley SM, Chiarappa-Zucca ML, Turteltaub KW, Newman LS. Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway. J Immunotoxicol. 2015 Apr-Jun; 12(2):181-7.
Score: 0.069
-
Sawyer RT, Abraham JL, Daniloff E, Newman LS. Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas. J Occup Environ Med. 2005 Dec; 47(12):1218-26.
Score: 0.038
-
Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 01; 171(1):54-60.
Score: 0.035
-
Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):470-7.
Score: 0.035
-
Infante PF, Newman LS. Beryllium exposure and chronic beryllium disease. Lancet. 2004 Feb 07; 363(9407):415-6.
Score: 0.034
-
Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
Score: 0.033
-
Maier LA, Kittle LA, Mroz MM, Newman LS. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Am J Ind Med. 2003 Jun; 43(6):592-601.
Score: 0.032
-
Maier L, Martyny J, Mroz M, McGrath D, Lympany P, duBois R, Zhang L, Murphy J, Newman LS. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease. Chest. 2002 Mar; 121(3 Suppl):81S.
Score: 0.030
-
Sawyer RT, Maier LA, Kittle LA, Newman LS. Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol. 2002 Feb; 2(2-3):249-61.
Score: 0.029
-
Harris J, Bartelson BB, Barker E, Balkissoon R, Kreiss K, Newman LS. Serum neopterin in chronic beryllium disease. Am J Ind Med. 1997 Jul; 32(1):21-6.
Score: 0.021
-
Daniloff EM, Lynch DA, Bartelson BB, Newell JD, Bernstein SM, Newman LS. Observer variation and relationship of computed tomography to severity of beryllium disease. Am J Respir Crit Care Med. 1997 Jun; 155(6):2047-56.
Score: 0.021
-
Inoue Y, Cornebise M, Daniloff E, Lloyd J, Tinkle S, King TE, Newman LS. Mast cell-associated basic fibroblast growth factor in the fibrotic response to environmental toxins. The Beryllium Model. Chest. 1996 Mar; 109(3 Suppl):43S-44S.
Score: 0.019
-
Maier LA, Barkes BQ, Mroz M, Rossman MD, Barnard J, Gillespie M, Martin A, Mack DG, Silveira L, Sawyer RT, Newman LS, Fontenot AP. Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease. Respir Med. 2012 Dec; 106(12):1810-3.
Score: 0.015
-
Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1680-8.
Score: 0.014
-
Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. 2010 Oct; 43(4):458-64.
Score: 0.013
-
Dobis DR, Sawyer RT, Gillespie MM, Huang J, Newman LS, Maier LA, Day BJ. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med. 2008 May 01; 177(9):1002-11.
Score: 0.011
-
Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007 Sep 15; 179(6):4255-62.
Score: 0.011
-
Fontenot AP, Palmer BE, Sullivan AK, Joslin FG, Wilson CC, Maier LA, Newman LS, Kotzin BL. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest. 2005 Oct; 115(10):2886-93.
Score: 0.009
-
Fontenot AP, Gharavi L, Bennett SR, Canavera SJ, Newman LS, Kotzin BL. CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells. J Clin Invest. 2003 Sep; 112(5):776-84.
Score: 0.008
-
Frome EL, Newman LS, Cragle DL, Colyer SP, Wambach PF. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology. 2003 Feb 01; 183(1-3):39-56.
Score: 0.008
-
Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest. 2002 Nov; 110(10):1473-82.
Score: 0.008
-
Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A. 2000 Nov 07; 97(23):12717-22.
Score: 0.007
-
Kreiss K, Miller F, Newman LS, Ojo-Amaize EA, Rossman MD, Saltini C. Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol. 1994 May; 71(2):123-9.
Score: 0.004
-
Kraft M, Mortenson RL, Colby TV, Newman L, Waldron JA, King TE. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis. 1993 Oct; 148(4 Pt 1):1093-101.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|